No - I don't think it is that simple David.

Sorry - I don't recall the details but it is related to the underlying program structure. There's stuff in ILE programs in terms of multiple entry points that the debugger can exploit and they just don't exist in OPM programs.



On Mar 26, 2020, at 4:47 PM, David Gibbs via WDSCI-L <wdsci-l@xxxxxxxxxxxxxxxxxx> wrote:

On 3/25/20 12:32 PM, Belcher, Doug [COMRES/WR/STL] wrote:
I have an OPM program that calls and OPM program and I'm stuck on how to get
them both into debug. I know on GS that I can STRDBG and then ADDPGM but how
do I do it in RDi?

I've never understood the technical reasons that RDi can't put a SEP on OPM programs directly.

Maybe it has to do with the activation group?

david

--
IBM i on Power Systems: For when you can't afford to be out of business!

I'm riding in the American Diabetes Association's Tour de Cure to raise money
for diabetes research, education, advocacy, and awareness. You can make a
tax-deductible donation to my ride by visiting https://mideml.diabetessucks.net.

You can see where my donations come from by visiting my interactive donation map
... https://mideml.diabetessucks.net/map (it's a geeky thing).

I may have diabetes, but diabetes doesn't have me!
--
This is the Rational Developer for IBM i / Websphere Development Studio Client for System i & iSeries (WDSCI-L) mailing list
To post a message email: WDSCI-L@xxxxxxxxxxxxxxxxxx
To subscribe, unsubscribe, or change list options,
visit: https://lists.midrange.com/mailman/listinfo/wdsci-l
or email: WDSCI-L-request@xxxxxxxxxxxxxxxxxx
Before posting, please take a moment to review the archives
at https://archive.midrange.com/wdsci-l.

Help support midrange.com by shopping at amazon.com with our affiliate
link: https://amazon.midrange.com


This thread ...

Replies:

Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2020 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].